Body recomp on GLP-1s: how to lose fat without losing muscle

Here's a number that doesn't make it into the marketing for GLP-1 weight-loss drugs: in the STEP-1 and SURMOUNT-1 trials, 25 to 40 percent of the weight lost by participants was lean mass, not fat. For some patients it was even higher.

Lean-mass loss isn't unique to GLP-1s — any calorie deficit will produce some — but the magnitude of loss on these drugs makes the risk material. A patient who loses 40 pounds and 15 of them are muscle ends up smaller but metabolically worse off, with weaker bones, lower resting metabolic rate, and a body that will rebound weight faster the moment they stop the medication.

The good news: muscle loss is largely controllable. Here's what the literature and clinical experience say about doing it right.

Protein, in real numbers.

The single highest-leverage variable is protein intake. The targets that hold up in the muscle-preservation literature:

• 1.0 g protein per pound of target body weight per day is a strong default. For a patient targeting 160 lb, that's 160 g/day.
• 30–40 g protein at the first meal of the day. Distributing protein across meals (not loading it all at dinner) improves muscle protein synthesis.
• Leucine matters. Whey, eggs, chicken, and beef are leucine-dense and trigger muscle protein synthesis more effectively than plant sources at the same gram count.

The challenge on a GLP-1 isn't picking the protein — it's actually eating it when your appetite is suppressed. Practical tactics:

• Start every meal with the protein first. If you fill on rice and bread, you won't get to the chicken.
• A 30 g protein shake on rough-appetite days is a worthwhile fallback.
• Greek yogurt, cottage cheese, and shaved deli meat are easy snacks when the appetite isn't there.

Resistance training is non-negotiable.

Walking is great for cardiovascular health and not very useful for muscle preservation. The signal that tells your body to keep muscle during a caloric deficit is resistance training.

Realistic minimum:

• 3 sessions per week of full-body resistance training, 45–60 minutes each.
• Compound movements as the foundation: squat or leg press, hinge (deadlift, RDL, hip thrust), upper push (bench, overhead press), upper pull (row, lat pulldown).
• Sets in the 6–10 rep range with a weight you'd fail at 12 — heavy enough to send the keep-this-muscle signal.

Patients who do this preserve significantly more lean mass through GLP-1 loss than patients who only walk or only do bodyweight workouts. It's a robust finding.

Pace matters.

Losing 1.5–2 lb per week is the sweet spot for body recomp. Faster than that and the body sheds more lean mass. If you're losing 4+ lb per week consistently:

• Your protein and calorie intake may be too low.
• The dose may need to come down or hold steady longer.
• You may be underestimating water-weight effects in the early weeks.

We watch this with our patients. Aggressive early loss looks like a win and usually isn't.

What "the rebound" actually is.

The reason GLP-1 patients regain weight after stopping isn't because the drug is magic — it's because they ended treatment with a meaningfully lower resting metabolic rate (from lost muscle) and a meaningfully smaller body that requires fewer calories. Eat the same way you ate at 200 lb when you're now metabolically a 170-lb person with less muscle, and you rebound.

The patients who don't rebound:

• Preserved muscle through the loss.
• Built habits during the loss that work at the new body size.
• Came off the drug slowly with their clinician's guidance.

Monitoring that matters.

Scale weight alone is the worst measurement on a GLP-1. Better:

• DEXA or InBody scan at baseline and every 3 months. You want fat mass dropping faster than lean mass.
• Waist circumference monthly.
• Strength markers — your training weights should hold steady or trend up, not collapse.
• Bloodwork — HbA1c, lipids, liver enzymes, ferritin.

The before/after photo is the easy part. The body composition behind the photo is what determines whether you keep the result.

Editorial disclosure: This article is for informational purposes only and does not constitute medical advice. All treatments at DirectCare AI are prescribed by US-licensed clinicians based on individual medical evaluation. Compounded medications are not FDA-approved as finished products; their active ingredients are individually FDA-approved. Always consult a US-licensed clinician before starting or changing any therapy.